The STOX1 genotype associated with pre-eclampsia leads to a reduction of trophoblast invasion by α-T-catenin upregulation

Human Molecular Genetics

Volumn 19, Issue 13, 2010, Pages 2658-2667

  van Dijk, Marie ^a,b   van Bezu, Jan ^a   van Abel, Daan ^a   Dunk, Caroline ^b   Blankenstein, Marinus A ^a   Oudejans, Cees B M ^a   Lye, Stephen J ^b,c,d  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA T CATENIN; CATENIN; PROTEIN KINASE B; PROTEIN STOX1; TRANSCRIPTION FACTOR; UBIQUITIN; UNCLASSIFIED DRUG; ALPHA CATENIN; CARRIER PROTEIN; CTNNA3 PROTEIN, HUMAN; FORKHEAD TRANSCRIPTION FACTOR; STOX1 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RISK FACTOR; TROPHOBLAST; UPREGULATION; ALLELE; CELL ADHESION; FEMALE; GENETICS; METABOLISM; PATHOLOGY; PREGNANCY;

ALLELES; ALPHA CATENIN; CARRIER PROTEINS; CELL ADHESION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENETIC ASSOCIATION STUDIES; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PROTO-ONCOGENE PROTEINS C-AKT; TROPHOBLASTS; UP-REGULATION;

EID: 77954162320     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddq152     Document Type: Article

References (36)

1. van Dijk, M., Mulders, J., Poutsma, A., Könst, A.A., Lachmeijer, A.M., Dekker, G.A., Blankenstein, M.A. and Oudejans, C.B. (2005) Maternal segregation of the Dutch preeclampsia locus at 10q22 with a new member of the winged helix gene family. Nat. Genet., 37, 514-519.
2. Berends, A.L., Bertoli-Avella, A.M., de Groot, C.J., van Duijn, C.M., Oostra, B.A. and Steegers, E.A. (2007) STOX1 gene in pre-eclampsia and intrauterine growth restriction. BJOG, 114, 1163-1167.
3. Kamei, T., Jones, S.R., Chapman, B.M., MCGonigle, K.L., Dai, G. and Soares, M.J. (2002) The phosphatidylinositol 3-kinase/Akt signaling pathway modulates the endocrine differentiation of trophoblast cells. Mol. Endocrinol., 16, 1469-1481.
4. Zhao, X., Gan, L., Pan, H., Kan, D., Majeski, M., Adam, S.A. and Unterman, T.G. (2004) Multiple elements regulate nuclear/cytoplasmic shuttling of FOXO1: characterization of phosphorylation- and 14-3-3-dependent and -independent mechanisms. Biochem. J., 378, 839-849.
5. Matsuzaki, H., Daitoku, H., Hatta, M., Tanaka, K. and Fukamizu, A. (2003) Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation. Proc. Natl Acad. Sci. USA, 20, 11285-11290.
6. Obsil, T. and Obsilova, V. (2008) Structure/function relationships underlying regulation of FOXO transcription factors. Oncogene, 27, 2263-2275.
7. Janes, S.M., Ofstad, T.A., Campbell, D.H., Watt, F.M. and Prowse, D.M. (2004) Transient activation of FOXN1 in keratinocytes induces a transcriptional programme that promotes terminal differentiation: contrasting roles of FOXN1 and Akt. J. Cell Sci., 117, 4157-4168.
8. Wolfrum, C., Besser, D., Luca, E. and Stoffel, M. (2003) Insulin regulates the activity of forkhead transcription factor Hnf-3β6 /Foxa-2 by Akt-mediated phosphorylation and nuclear/cytosolic localization. Proc. Natl Acad. Sci. USA, 100, 11624-11629.
9. Dahle, M.K., Grønning, L.M., Cederberg, A., Blomhoff, H.K., Miura, N., Enerbäck, S., Tasken, K.A. and Tasken, K. (2002) Mechanisms of FOXC2- and FOXD1-mediated regulation of the RIα subunit of cAMP-dependent protein kinase include release of transcriptional repression and activation by protein kinase Bα and cAMP. J. Biol. Chem., 277, 22902-22908.
10. Aoki, M., Jiang, H. and Vogt, P.K. (2004) Proteosomal degradation of the FoxO1 transcriptional regulator in cells transformed by the P3k and Akt oncoproteins. Proc. Natl Acad. Sci. USA, 101, 13613-13617.
11. Saleem, R.A., Banerjee-Basu, S., Berry, F.B., Baxevanis, A.D. and Walter, M.A. (2001) Analyses of the effects that disease-causing missense mutations have on the structure and function of the winged-helix protein FOXC1. Am. J. Hum. Genet., 68, 627-641.
12. Oudejans, C.B., Mulders, J., Lachmeijer, A.M., van Dijk, M., Könst, A.A., Westerman, B.A., van Wijk, I.J., Leegwater, P.A., Kato, H.D., Matsuda, T. et al. (2004) The parent-of-origin effect of 10q22 in pre-eclamptic females coincides with two regions clustered for genes with down-regulated expression in androgenetic placentas. Mol. Hum. Reprod., 10, 589-598.
13. Redman, C.W. and Sargent, I.L. (2005) Latest advances in understanding preeclampsia. Science, 308, 1592-1594.
14. van Dijk, M., Mulders, J., Könst, A., Janssens, B., van Roy, F., Blankenstein, M. and Oudejans, C. (2004) Differential downregulation of alphaT-catenin expression in placenta: trophoblast cell type-dependent imprinting of the CTNNA3 gene. Gene Exp. Patterns, 5, 61-65.
15. Janssens, B., Goossens, S., Staes, K., Gilbert, B., van Hengel, J., Colpaert, C., Bruyneel, E., Mareel, M. and van Roy, F. (2001) alphaT-catenin: a novel tissue-specific beta-catenin-binding protein mediating strong cell-cell adhesion. J. Cell Sci., 114, 3177-3188.
16. Brown, L.M., Lacey, H.A., Baker, P.N. and Crocker, I.P. (2005) E-cadherin in the assessment of aberrant placental cytotrophoblast turnover in pregnancies complicated by pre-eclampsia. Histochem. Cell. Biol., 124, 499-506.
17. Li, H.W., Cheung, A.N., Tsao, S.W., Cheung, A.L. and O.W.S. (2003) Expression of e-cadherin and beta-catenin in trophoblastic tissue in normal and pathological pregnancies. Int. J. Gynecol. Pathol., 22, 63-70.
18. Benian, A., Madazli, R., Aksu, F., Uzun, H. and Aydin, S. (2002) Plasma and placental levels of interleukin-10, transforming growth factor-beta1, and epithelial-cadherin in preeclampsia. Obstet. Gynecol., 100, 327-331.
19. Zhou, Y., Damsky, C.H. and Fisher, S.J. (1997) Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J. Clin. Invest., 99, 2152-2164.
20. Zhou, Y., Fisher, S.J., Janatpour, M., Genbacev, O., Dejana, E., Wheelock, M. and Damsky, C.H. (1997) Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J. Clin. Invest., 99, 2139-2151.
21. Kee, Y., Hwang, B.J., Sternberg, P.W. and Bronner-Fraser, M. (2007) Evolutionary conservation of cell migration genes: from nematode neurons to vertebrate neural crest. Genes Dev., 21, 391-396.
22. Liu, X., Sun, Y., Constantinescu, S.N., Karam, E., Weinberg, R.A. and Lodish, H.F. (2007) Transforming growth factor beta-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. Proc. Natl Acad. Sci. USA, 94, 10669-10674.
23. Youn, J.H. and Shin, J.S. (2006) Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion. J. Immunol., 177, 7889-7897.
24. Baczyk, D., Dunk, C., Huppertz, B., Maxwell, C., Reister, F., Giannoulias, D. and Kingdom, J.C. (2006) Bi-potential behaviour of cytotrophoblasts in first trimester chorionic villi. Placenta, 27, 367-374.
25. Zhou, G.L., Tucker, D.F., Bae, S.S., Bhatheja, K., Birnbaum, M.J. and Field, J. (2006) Opposing roles for Akt1 and Akt2 in Rac/Pak signaling and cell migration. J. Biol. Chem., 281, 36443-36453.
26. Kotelevets, L., van Hengel, J., Bruyneel, E., Mareel, M., van Roy, F. and Chastre, E. (2005) Implication of the MAGI-1b/PTEN signalosome in stabilization of adherens junctions and suppression of invasiveness. FASEB J., 19, 115-117.
27. Subauste, M.C., Nalbant, P., Adamson, E.D. and Hahn, K.M. (2005) Vinculin controls PTEN protein level by maintaining the interaction of the adherens junction protein bet1 beta-catenin with the scaffolding protein MAGI-2. J. Biol. Chem., 280, 5676-5681.
28. Roten, L.T., Johnson, M.P., Forsmo, S., Fitzpatrick, E., Dyer, T.D., Brennecke, S.P., Blangero, J., Moses, E.K. and Austgulen, R. (2009) Association between the candidate susceptibility gene ACVR2A on chromosome 2q22 and pre-eclampsia in a large Norwegian population-based study (the HUNT study). Eur. J. Hum. Genet., 17, 250-257.
29. Arngrímsson, R., Sigurardottir, S., Frigge, M.L., Bjarnadottir, R.I., Jónsson, T., Stefánsson, H., Baldursdóttir, A., Einarsdóttir, A.S., Palsson, B., Snorradóttir, S. et al. (1999) A genome-wide scan reveals a maternal susceptibility locus for pre-eclampsia on chromosome 2p13. Hum. Mol. Genet., 8, 1799-1805.
30. Iglesias-Platas, I., Monk, D., Jebbink, J., Buimer, M., Boer, K., van der Post, J., Hills, F., Apostolidou, S., Ris-Stalpers, C., Stanier, P. and Moore, G.E. (2007) STOX1 is not imprinted and is not likely to be involved in preeclampsia. Nat. Genet., 39, 279-280.
31. Kivinen, K., Peterson, H., Hiltunen, L., Laivuori, H., Heino, S., Tiala, I., Knuutila, S., Rasi, V. and Kere, J. (2007) Evaluation of STOX1 as a preeclampsia candidate gene in a population-wide sample. Eur. J. Hum. Genet., 15, 494-497.
32. Choy, M.Y., St Whitley, G. and Manyonda, I.T. (2000) Efficient, rapid and reliable establishment of human trophoblast cell lines using poly-L-ornithine. Early Pregnancy, 4, 124-143.
33. Chou, J.Y. (1979) Human placental cells transformed by tsA mutants of simian virus 40: a model system for the study of placental functions. Proc. Natl Acad. Sci. USA, 75, 1409-1413.
34. Westerman, B.A., Neijenhuis, S., Poutsma, A., Steenbergen, R.D., Breuer, R.H., Egging, M., van Wijk, I.J. and Oudejans, C.B. (2002) Quantitative reverse transcription-polymerase chain reaction measurement of HASH1 (ASCL1), a marker for small cell lung carcinomas with neuroendocrine features. Clin. Cancer Res., 8, 1082-1086.
35. Vanpoucke, G., Goossens, S., De Craene, B., Gilbert, B., van Roy, F. and Berx, G. (2004) GATA-4 and MEF2C transcription factors control the tissue-specific expression of the alphaT-catenin gene CTNNA3. Nucleic Acids Res., 32, 4155-4165.
36. Forbes, K., Desforges, M., Garside, R., Aplin, J.D. and Westwood, M. (2009) Methods for siRNA-mediated reduction of mRNA and protein expression in human placental explants, isolated primary cells and cell lines. Placenta, 30, 124-129.